Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TIMM23 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
mRNA | DISP2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
mRNA | AL356585.1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
mRNA | EPC2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
mRNA | ZDHHC17 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
mRNA | AL135745.1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
mRNA | GALNT18 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
mRNA | ZKSCAN2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | BCLAF1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
mRNA | MXI1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |